SONTUZUMAB
UNII 3VD89OE565

Substance Identification & Data

This profile provides standardized clinical and technical data for Sontuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3VD89OE565.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 372075-37-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3VD89OE565
CAS Registry Number
372075-37-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SONTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8438
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sontuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SONTUZUMAB

Common Names & Synonyms

EPITUMOMAB
EPITUMOMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (HUMAN-MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HMFG-1, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL HMFG-1, DIMER
SONTUZUMAB [INN]
SONTUZUMAB [WHO-DD]

Technical Codes

AS-1402
HUHMFG-1